logo
logo
Sign in

Dengue Vaccines Market Complete Analytical Report for 2031 with Key Players- GeneOne Life Science Inc., Sanofi Pasteur Limited, GlaxoSmithKline Plc., Biological E Ltd.

avatar
Vijay Kundekar

A recent market study published by FMI on the dengue vaccines market includes global industry analysis for 2016-2020 & opportunity assessment for 2021-2031, and delivers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters of the dengue vaccines market, growth prospects of the market are obtained with maximum precision.

Dengue Vaccines Market: Taxonomy

The global dengue vaccines market is segmented in detail to cover every aspect of the market and present complete market intelligence to the reader.

Product

  • CYD-TDV (Dengvaxia)

End-User

  • Hospitals
  • Government Institutes
  • Non-governmental Organizations (NGOs)

Region

  • North America (US and Canada)
  • Latin America (Brazil, Mexico, Venezuela and Rest of LATAM)
  • Western Europe (Germany, UK, France, Spain, Italy and Rest of Western Europe)
  • Eastern Europe (Russia, Poland and Rest of Eastern Europe)
  • APEJ (The Philippines, Indonesia, Malaysia, Thailand, Vietnam, India and Rest of APEJ)
  • Japan
  • Middle East & Africa (GCC, Northern Africa, South Africa and Rest of MEA)

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1763 

Report Chapters

Chapter 01 – Executive Summary

The report initiates with the executive summary of the dengue vaccines market, which includes a summary of key findings and statistics of the market. It also includes the demand-side & supply-side trends about the dengue vaccines market.

Chapter 02 – Dengue Vaccines Market Introduction

This chapter provides a detailed taxonomy in the form of segments.

Chapter 03 – Dengue Vaccines Market Analysis Scenario

This chapter elaborates on the overall market size (US$ Mn) and forecast- providing information regarding the market size and Y-o-Y growth estimates. Furthermore, this section provides projections on the absolute $ opportunity across key segments and geographies for the forthcoming decade.

Chapter 04 – Dengue Vaccines Market Dynamics and USPs

This chapter explains key macro-economic factors that are expected to influence the growth of the dengue vaccines market over the forecast period. Along with the macroeconomic factors, this section also highlights the value chain and forecast factors for the dengue vaccines market. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided.

Chapter 05 – Global Dengue Vaccines Market Analysis by Product

This chapter provides details about the dengue vaccines market based on product, and has been segmented as CYD-TDV (Dengvaxia). In this chapter, readers can understand the market attractive analysis based on product.

Chapter 06 – Global Dengue Vaccines Market Analysis by End-User

Based on end-user, the dengue vaccines market is segmented into hospitals, government institutes and NGOs. In this chapter, readers can find information about the key trends and developments in the dengue vaccines market and market attractiveness analysis based on end-user.

Chapter 07 – Global Dengue Vaccines Market Analysis 2016-2020 & Opportunity Assessment 2021-2031, by Region

This chapter explains how the dengue vaccines market will grow across several geographic regions such as North America, APEJ, Western Europe, Eastern Europe, Latin America, Japan and Middle East & Africa.

Get Full Report Buy Now @ https://www.futuremarketinsights.com/checkout/1763 

Chapter 08 – North America Dengue Vaccines Market Analysis 2016-2020 & Opportunity Assessment 2021-2031

This chapter includes a detailed analysis of the growth of the North America dengue vaccines market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on end use and countries in North America.

Chapter 09 – Latin America Dengue Vaccines Market Analysis 2016-2020 & Opportunity Assessment 2021-2031

This chapter provides the growth scenario of the dengue vaccines market in Latin America countries such as Brazil, Mexico, Venezuela and the Rest of Latin America. Along with this, an assessment of the market across target segments has been provided.

Chapter 10 – Asia Pacific excluding Japan (APEJ) Dengue Vaccines Market Analysis 2016-2020 & Opportunity Assessment 2021-2031

Important growth prospects of the Dengue vaccines market based on its end use in several countries such as the Philippines, Indonesia, Malaysia, Thailand, Vietnam, India and Rest of APEJ are included in this chapter.

Chapter 11 – Western Europe Dengue Vaccines Market Analysis 2016-2020 & Opportunity Assessment 2021-2031

Important growth prospects of the dengue vaccines market based on its end use in several countries such as Germany, U.K., France, Spain, Italy and Rest of Western Europe are included in this chapter.

Chapter 12 – Eastern Europe Dengue Vaccines Market Analysis 2016-2020 & Opportunity Assessment 2021-2031

Important growth prospects of the dengue vaccines market based on its end use in several countries such as Russia, Poland and Rest of Eastern Europe are included in this chapter.

Chapter 13 – Japan Dengue Vaccines Market Analysis 2016-2020 & Opportunity Assessment 2021-2031

This chapter highlights the growth of the dengue vaccines market in Japan. This section also helps readers understand the key factors that are responsible for the growth of the dengue vaccines market in Japan.

Chapter 14 – Middle East & Africa Dengue vaccines Market Analysis 2016-2020 & Opportunity Assessment 2021-2031

This chapter highlights the growth of the dengue vaccines market in Middle East & Africa by focusing on GCC, Northern Africa, South Africa and Rest of MEA. This section also helps readers understand the key factors that are responsible for the growth of the dengue vaccines market in Middle East and Africa.

Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-1763 

Chapter 15 – Competition Landscape

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the dengue vaccines market, along with detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Sanofi Pasteur Limited, Takeda Pharmaceutical Company Limited, Merck & Co. Inc., GlaxoSmithKline Plc., GeneOne Life Science Inc., Medigen Vaccine Biologics Corporation, Panacea Biotec Limited, Sun Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd. and Biological E Ltd. among others.  

Chapter 16 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the dengue vaccines market report.

Chapter 17 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the dengue vaccines market.  

collect
0
avatar
Vijay Kundekar
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more